NAUT
Nautilus Biotechnolgy, Inc. Common Stock
stockNASDAQ
born from the founders' recognition that their diverse but complementary skills and experiences would enable them to successfully address challenges that others had not, the company set about solving a vexing problem: how to bring true proteomics to the world in a way that accelerates therapeutic development, dramatically improves medical diagnostics, and makes personalized and predictive medicine a reality. the extraordinary team at nautilus represents a wide spectrum of disciplines and expertise, including: protein chemists, chip designers, molecular biologists, data scientists, material scientists, biophysicists, optical engineers, microfluidics engineers, bioinformaticists, software engineers, and more. nautilus is positioned to revolutionize proteomics, transform the way drugs are developed, and significantly improve the way human health is managed.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 2.25 | 2026-10-09 | -9.11% | -2.178 |
| 1M | 0.97 | 2026-09-17 | +110.46% | 1.340 |
| 3M | 1.74 | 2026-07-17 | +17.53% | 0.698 |
| 6M | 3.03 | 2026-04-17 | -32.51% | 1.117 |
| 1Y | 0.97 | 2025-10-17 | +110.83% | 1.429 |
| 2Y | 2.87 | 2024-10-17 | -28.75% | — |
| 5Y | 5.56 | 2021-10-18 | -63.22% | 1.573 |
Nautilus Biotechnolgy, Inc. Common Stock (NASDAQ:NAUT) stock price today is $2.05, and today's volume is 6,455,172. NAUT is down 5.324% today. The 30 day average volume is 6.75M. NAUT market cap is $260.24M with 127.26M shares outstanding.